AAAAAA
Results:
1-8
|
Results: 8
Authors:
DEKKER JH
FRANSE LV
VALK GD
HEINE RJ
VANEIJK JTM
Citation: Jh. Dekker et al., HOW DOES THE GENERAL-PRACTITIONER APPROACH THE CLUSTERING OF CARDIOVASCULAR RISK-FACTORS IN TYPE-2 DIABETES, Diabetologia, 41, 1998, pp. 153-153
Authors:
VALK GD
GROOTENHUIS PA
VANEIJK JTM
BOUTER LM
BERTELSMANN FW
Citation: Gd. Valk et al., THE ROLE OF SENSORY SYMPTOMS IN THE ASSESSMENT OF DIABETIC POLYNEUROPATHY, Diabetologia, 41, 1998, pp. 1052-1052
Authors:
FRANSE LV
VALK GD
DEKKER JH
HEINE RJ
VANEIJK JTM
Citation: Lv. Franse et al., NUMBNESS OF THE FEET IS A POOR INDICATOR FOR POLYNEUROPATHY IN TYPE-2DIABETIC-PATIENTS, Diabetologia, 41, 1998, pp. 1053-1053
Authors:
VALK GD
DESONNAVILLE JJJ
VANHOUTUM WH
HEINE RJ
VANEIJK JTM
BOUTER LM
BERTELSMANN FW
Citation: Gd. Valk et al., THE ASSESSMENT OF DIABETIC POLYNEUROPATHY IN DAILY CLINICAL-PRACTICE - REPRODUCIBILITY AND VALIDITY OF SEMMES-WEINSTEIN MONOFILAMENTS EXAMINATION AND CLINICAL NEUROLOGICAL EXAMINATION, Muscle & nerve, 20(1), 1997, pp. 116-118
Authors:
VALK GD
KAPPELLE AC
TJONATSIEN AML
BRAVENBOER B
BAKKER K
MICHELS RPJ
GROENHOUT CM
BERTELSMANN FW
Citation: Gd. Valk et al., TREATMENT OF DIABETIC POLYNEUROPATHY WITH THE NEUROTROPHIC PEPTIDE ORG-2766, Journal of neurology, 243(3), 1996, pp. 257-263
Authors:
VALK GD
VANHOUTUM WH
DESONNAVILLE JJJ
HEINE RJ
BERTELSMANN FW
Citation: Gd. Valk et al., DETECTION OF DIABETIC POLYNEUROPATHY IN DAILY CLINICAL-PRACTICE, Diabetologia, 38, 1995, pp. 235-235
Authors:
VALK GD
GROOTENHUIS PA
BOUTER LM
BERTELSMANN FW
Citation: Gd. Valk et al., COMPLAINTS OF NEUROPATHY RELATED TO THE CLINICAL AND NEUROPHYSIOLOGICAL ASSESSMENT OF NERVE FUNCTION IN PATIENTS WITH DIABETES-MELLITUS, Diabetes research and clinical practice, 26(1), 1994, pp. 29-34
Authors:
BERTELSMANN FW
BAKKER K
KAPELLE AC
MICHELS RCJ
TJONATSIEN AML
VALK GD
Citation: Fw. Bertelsmann et al., EFFICACY OF A NEUROTROPHIC PEPTIDE (ORG-2766) IN TREATING DIABETIC POLYNEUROPATHY, Diabetologia, 37, 1994, pp. 10000178-10000178
Risultati:
1-8
|